首页> Blood advances> Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments.

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments.

导出 LinkOut

翻译打印收藏纠错

第一作者： Halina H L,Leung

第一单位： Department of Haematology, St. George and Sutherland Clinical Campuses, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.

作者： Halina H L,Leung ^[1] ; Zohra,Ahmadi ^[1] ; Brendan,Lee ^[2] ; John,Casey ^[3] ; Sumita,Ratnasingam ^[4] ; Steven E,McKenzie ^[5] ; Jose,Perdomo ^[6] ; Beng H,Chong ^[7]

作者单位： Department of Haematology, St. George and Sutherland Clinical Campuses, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia. ^[1] Biological Resources Imaging Laboratory, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, Australia. ^[2] Department of Haematology, Townsville University Hospital and Health Service, Townsville, QLD, Australia. ^[3] Department of Haematology, University Hospital Geelong, Geelong, VIC, Australia. ^[4] Department of Medicine, Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA. ^[5] Department of Haematology, St. George and Sutherland Clinical Campuses, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.;Department of Haematology, Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. ^[6] Department of Haematology, St. George and Sutherland Clinical Campuses, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.;Department of Haematology, New South Wales Health Pathology, Sydney, NSW, Australia. ^[7]

医学主题词动物(Animals);人类(Humans);小鼠(Mice);抗凝药(Anticoagulants);硫酸皮肤素(Dermatan Sulfate);疾病模型, 动物(Disease Models, Animal);纤维蛋白溶解药(Fibrinolytic Agents);出血(Hemorrhage);肝素(Heparin);免疫球蛋白G(Immunoglobulin G);免疫球蛋白类, 静脉内(Immunoglobulins, Intravenous);血小板活化(Platelet Activation);血小板因子4(Platelet Factor 4);紫癜, 血小板减少性, 特发性(Purpura, Thrombocytopenic, Idiopathic);受体, IgG(Receptors, IgG);血小板减少(Thrombocytopenia);血栓形成(Thrombosis);疫苗(Vaccines)

DOI 10.1182/bloodadvances.2024013883

PMID 39293086

发布时间 2025-08-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Blood advances

2024年8卷22期

5744-5752页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

点击下载本期目录封面

Blood advances

2024年8卷22期

5744-5752页

检索历史清除

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

检索历史清除